Ahmed M Harraz, A. El-Nahas, M. Nabeeh, M. Laymon, Khalid Z Sheir, H. El-Kappany, Y. Osman
{"title":"Development and validation of a simple stone score (SSS) to estimate the probability of residual stones prior to percutaneous nephrolithotomy.","authors":"Ahmed M Harraz, A. El-Nahas, M. Nabeeh, M. Laymon, Khalid Z Sheir, H. El-Kappany, Y. Osman","doi":"10.23736/S0393-2249.20.04055-2","DOIUrl":null,"url":null,"abstract":"BACKGROUND\nThe purpose is to develop and internally validate a simple stone score (SSS) to estimate the probability of clinically significant residual fragments (CSRF) prior to percutaneous nephrolithotomy (PNL).\n\n\nMETHODS\nThe files of 1170 PNL procedures between January and December 2015 were evaluated. CT-derived stone characteristics were examined. Caliceal stone distribution (CSD) was assigned three grades based on the number of calices involved regardless of the renal pelvis (I: no or single calix; II: more than one calix; III: more than 2 calices or complete staghorn stones). CSRF was defined as any residuals >4 mm in postoperative CT. A logistic regression model to predict the CSRF was fitted and coefficients were used to develop the SSS. The SSS was validated by discrimination, calibration, and decision curve analysis (DCA).\n\n\nRESULTS\nPatients' data were split into training (936, 80%) and validating (234, 20%) datasets. In the training partition, independent predictors of CSRF were CSD-grade II (OR: 4.2; 95%CI: 2.5-7; p<0.001), grade III (OR: 7.8; 95%CI: 4.2-14.4; p<0.001) and largest stone diameter (LSD) (OR:1.3; 95%CI: 1.1-1.6; p<0.001). Score points 0, 1, 2, and 0, 3, 9 were given to LSD <30, 30- 40, >40 mm, and CSD grades I, II, III, respectively. Discrimination of the SSS was 0.79 and after 10-fold cross-validation and internal validation was 0.86. The calibration plot and DCA highlighted the validity and clinical significance of the SSS.\n\n\nCONCLUSIONS\nThe novel SSS could be used to describe the risk of CSRF prior to PNL. Further studies are invited for external validation.","PeriodicalId":49015,"journal":{"name":"Minerva Urologica E Nefrologica","volume":"26 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Minerva Urologica E Nefrologica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23736/S0393-2249.20.04055-2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 2
Abstract
BACKGROUND
The purpose is to develop and internally validate a simple stone score (SSS) to estimate the probability of clinically significant residual fragments (CSRF) prior to percutaneous nephrolithotomy (PNL).
METHODS
The files of 1170 PNL procedures between January and December 2015 were evaluated. CT-derived stone characteristics were examined. Caliceal stone distribution (CSD) was assigned three grades based on the number of calices involved regardless of the renal pelvis (I: no or single calix; II: more than one calix; III: more than 2 calices or complete staghorn stones). CSRF was defined as any residuals >4 mm in postoperative CT. A logistic regression model to predict the CSRF was fitted and coefficients were used to develop the SSS. The SSS was validated by discrimination, calibration, and decision curve analysis (DCA).
RESULTS
Patients' data were split into training (936, 80%) and validating (234, 20%) datasets. In the training partition, independent predictors of CSRF were CSD-grade II (OR: 4.2; 95%CI: 2.5-7; p<0.001), grade III (OR: 7.8; 95%CI: 4.2-14.4; p<0.001) and largest stone diameter (LSD) (OR:1.3; 95%CI: 1.1-1.6; p<0.001). Score points 0, 1, 2, and 0, 3, 9 were given to LSD <30, 30- 40, >40 mm, and CSD grades I, II, III, respectively. Discrimination of the SSS was 0.79 and after 10-fold cross-validation and internal validation was 0.86. The calibration plot and DCA highlighted the validity and clinical significance of the SSS.
CONCLUSIONS
The novel SSS could be used to describe the risk of CSRF prior to PNL. Further studies are invited for external validation.
期刊介绍:
The journal Minerva Urologica e Nefrologica publishes scientific papers on nephrology and urology. Manuscripts may be submitted in the form of Minerva opinion editorials, editorial comments, original articles, video illustrated articles, review articles and letters to the Editor.